Routine insider onboarding filing — no trading signal. Monitor future Form 4 filings for open-market purchases or sales by the new CFO.
Price Chart
Executive Summary
Keith Regnante filed a Form 3 initial statement of beneficial ownership upon becoming Chief Financial Officer of City Therapeutics, Inc. The filing discloses an option to purchase 182,317 shares at $9.10, vesting over four years. This is a routine insider onboarding filing with no market-moving information.
Key Facts
- Keith Regnante appointed as Chief Financial Officer of City Therapeutics, Inc.
- Initial beneficial ownership filing (Form 3) filed on October 15, 2026.
- Discloses a stock option to buy 182,317 shares at an exercise price of $9.10 per share.
- Option vests 25% on August 4, 2027, with the remainder in 36 equal monthly installments thereafter.
- Option expires on August 3, 2036.
Financial Impact
No immediate financial impact. Option grant is standard compensation for a new CFO.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-116357 |
| Document: 0001104659-26-116357-index-headers.html | 0001104659-26-116357 |
| Document: 0001104659-26-116357-index.html | 0001104659-26-116357 |
| Document: 0001104659-26-116357.txt | 0001104659-26-116357 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13D | $20.79 | awaiting T+5 | — | $20.86 (+0.34%) |
Oct 26, 2026 1d ago | SC 13G | $20.79 | awaiting T+5 | — | $20.86 (+0.34%) |
Oct 22, 2026 5d ago | SC 13G | $20.77 | awaiting T+5 | — | $20.86 (+0.43%) |
Oct 19, 2026 8d ago | Insider Cluster | $20.83 $20.86 | ▲ +0.14% | ▲ +0.06% | $20.86 (+0.14%) |
Oct 19, 2026 8d ago | Press Release | $20.83 $21.19 | ▲ +1.73% | ▲ +1.70% | $20.86 (+0.14%) |
Oct 16, 2026 11d ago | 424B4 | $21.46 $20.79 | ▼ −3.12% | ▼ −2.98% | $20.86 (−2.80%) |
Oct 16, 2026 11d ago | EFFECT | $22.40 $20.77 | ▼ −7.28% | ▼ −6.85% | $20.86 (−6.87%) |
Oct 15, 2026 12d ago | 3 | $22.40 $20.77 | ▼ −7.28% | ▼ −6.85% | $20.86 (−6.87%) |
Oct 15, 2026 12d ago | 3 | $22.40 $20.77 | ▼ −7.28% | ▼ −6.85% | $20.86 (−6.87%) |
Oct 15, 2026 12d ago | 3 | $22.40 $20.77 | ▼ −7.28% | ▼ −6.85% | $20.86 (−6.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers